{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:43:25Z","timestamp":1789530205085,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R25 DA021630"],"award-info":[{"award-number":["R25 DA021630"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.siny.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T21:00:33Z","timestamp":1349730033000},"page":"35-41","source":"Crossref","is-referenced-by-count":10,"title":["Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome"],"prefix":"10.1016","volume":"18","author":[{"given":"Gabrielle L.","family":"McLemore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamorah","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle B.","family":"Gauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2012.09.002_bib1","series-title":"Results from the 2010 National Survey on Drug Use and Health: summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2011"},{"key":"10.1016\/j.siny.2012.09.002_bib2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.siny.2012.09.002_bib3","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jama.2012.4526","article-title":"Epidemic of prescription opiate abuse and neonatal abstinence [Editorial]","volume":"307","author":"Hayes","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.siny.2012.09.002_bib4","series-title":"Monitoring the Future national results on adolescent drug use: overview of key findings, 2007","author":"Johnston","year":"2008"},{"key":"10.1016\/j.siny.2012.09.002_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1552-6909.2011.01330.x","article-title":"Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome","volume":"41","author":"Pritham","year":"2012","journal-title":"J\u00a0Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.siny.2012.09.002_bib6","first-page":"e441","article-title":"Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications","volume":"57","author":"Kelly","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.siny.2012.09.002_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbr.2010.03.022","article-title":"Prenatal oxycodone exposure impairs spatial learning and\/or memory in rats","volume":"212","author":"Davis","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.siny.2012.09.002_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/jp.2011.116","article-title":"Update on the pharmacologic management of neonatal abstinence syndrome","volume":"31","author":"Bio","year":"2011","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2012.09.002_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1542-2011.2011.00049.x","article-title":"Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care","volume":"56","author":"Goodman","year":"2011","journal-title":"J\u00a0Midwifery Women's Health"},{"key":"10.1016\/j.siny.2012.09.002_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOP.0b013e32834fdc3a","article-title":"Neonatal abstinence syndrome","volume":"24","author":"Jansson","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.siny.2012.09.002_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2004.08.027","article-title":"Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone","volume":"78","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.siny.2012.09.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.siny.2012.09.002_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopsych.2010.08.021","article-title":"Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine","volume":"69","author":"Goeldner","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.siny.2012.09.002_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/FPC.0b013e328322e73d","article-title":"From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics","volume":"19","author":"Chu","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.siny.2012.09.002_bib15","first-page":"e1","article-title":"Ondansetron use during pregnancy: a case series","volume":"19","author":"Ferreira","year":"2012","journal-title":"J\u00a0Popul Ther Clin Pharmacol"},{"issue":"8829","key":"10.1016\/j.siny.2012.09.002_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(92)92923-4","article-title":"Ondansetron and hyperemesis gravidarum","volume":"340","author":"Guikontes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2012.09.002_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0924-977X(02)00028-7","article-title":"The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: a combined in\u00a0vivo cerebral microdialysis and behavioural study","volume":"12","author":"Gray","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.siny.2012.09.002_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2005.02.002","article-title":"Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine","volume":"512","author":"Wu","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.siny.2012.09.002_bib19","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal. Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2012.09.002_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/PEC.0b013e31826289d9","article-title":"Recognizing serotonin toxicity in the pediatric emergency department","volume":"28","author":"Kant","year":"2012","journal-title":"Pediatr Emer Care"},{"key":"10.1016\/j.siny.2012.09.002_bib21","first-page":"519","article-title":"Drugs of abuse: management of intoxication and antidotes","volume":"100","author":"Montoya","year":"2010","journal-title":"EXS"},{"key":"10.1016\/j.siny.2012.09.002_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.siny.2012.09.002_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm0211-146","article-title":"Vaccines move forward against a range of addictions","volume":"17","author":"Chi","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.siny.2012.09.002_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.5.4.7556","article-title":"Vaccines against morphine\/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors","volume":"5","author":"Anton","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.siny.2012.09.002_bib25","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A\u00a0vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.siny.2012.09.002_bib26","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A\u00a0novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.siny.2012.09.002_bib27","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.siny.2012.09.002_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10408444.2011.653487","article-title":"The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy","volume":"42","author":"DeSesso","year":"2012","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.siny.2012.09.002_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.siny.2012.09.002_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00952990802122564","article-title":"Pharmacogenetic treatments for drug addiction: alcohol and opiates","volume":"34","author":"Haile","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.siny.2012.09.002_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jp.2009.183","article-title":"Maternal\u2013fetal and neonatal pharmacogenomics: a review of current literature","volume":"30","author":"Blumenfeld","year":"2010","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2012.09.002_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","article-title":"Are \u03bc-opioid receptor polymorphisms important for clinical opioid therapy?","volume":"11","author":"L\u00f6tsch","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.siny.2012.09.002_bib33","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.siny.2012.09.002_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(01)00294-9","article-title":"The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade","volume":"26","author":"Wand","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.siny.2012.09.002_bib35","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A\u00a0functional polymorphism of the [mu]-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.siny.2012.09.002_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00041444-200309000-00006","article-title":"A\u00a0genetic association study of the mu opioid receptor and severe opioid dependence","volume":"13","author":"Crowley","year":"2003","journal-title":"Psychiatric Genet"},{"key":"10.1016\/j.siny.2012.09.002_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001504","article-title":"Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden","volume":"9","author":"Bart","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.siny.2012.09.002_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1460-9592.2010.03389.x","article-title":"Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance","volume":"21","author":"Allegaert","year":"2011","journal-title":"Pediatric Anesthesia"},{"key":"10.1016\/j.siny.2012.09.002_bib39","unstructured":"University Hospital Inselspital B. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain (predictio). ClinicalTrials.gov [Internet]: National Library of Medicine (US) [2012; cited 12 A.D. Sept. 8]; Available from: URL: clinicaltrials.gov\/show\/NCT01179828."},{"key":"10.1016\/j.siny.2012.09.002_bib40","unstructured":"Columbia University. Effect of mu-opioid receptor genetics on 3 doses of spinal morphine for postoperative analgesia after cesarean section. ClinicalTrials.gov [Internet]: National Library of Medicine (US) [2012; cited 12 A.D. Sept. 8]. Available from: URL: clinicaltrials.gov\/show\/NCT01465191."},{"key":"10.1016\/j.siny.2012.09.002_bib41","unstructured":"Children's Research Institute. The use of methadone in newborn infants. ClinicalTrials.gov [Internet]: National Library of Medicine (US) [2012; cited 12 A.D. Sept. 8]; Available from: URL: clinicaltrials.gov\/show\/NCT01327079."},{"key":"10.1016\/j.siny.2012.09.002_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11920-010-0099-5","article-title":"Epigenetic regulation in substance use disorders","volume":"12","author":"McQuown","year":"2010","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.siny.2012.09.002_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1360-0443.2010.03321.x","article-title":"Drugs and addiction: an introduction to epigenetics","volume":"106","author":"Wong","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.siny.2012.09.002_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/npp.2008.108","article-title":"Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts","volume":"34","author":"Nielsen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.siny.2012.09.002_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00439-010-0807-6","article-title":"Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts","volume":"127","author":"Nielsen","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.siny.2012.09.002_bib46","doi-asserted-by":"crossref","first-page":"17835","DOI":"10.1523\/JNEUROSCI.3297-11.2011","article-title":"Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression","volume":"31","author":"Schwarz","year":"2011","journal-title":"J\u00a0Neurosci"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X12001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X12001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T19:19:26Z","timestamp":1583954366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X12001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1744165X12001035"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2012.09.002","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}